
Genevieve S. Alley
Examiner (ID: 9678, Phone: (571)270-1111 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 843 |
| Issued Applications | 465 |
| Pending Applications | 100 |
| Abandoned Applications | 305 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18353967
[patent_doc_number] => 11642351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-09
[patent_title] => Eslicarbazepine suspension
[patent_app_type] => utility
[patent_app_number] => 16/827534
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6978
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827534 | Eslicarbazepine suspension | Mar 22, 2020 | Issued |
Array
(
[id] => 18792695
[patent_doc_number] => 11826429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Pharmaceutical composition comprising brinzolamide
[patent_app_type] => utility
[patent_app_number] => 16/811674
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 9655
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/811674 | Pharmaceutical composition comprising brinzolamide | Mar 5, 2020 | Issued |
Array
(
[id] => 16086847
[patent_doc_number] => 20200197410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => D2O STABILIZED PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/805612
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805612
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/805612 | D2O stabilized pharmaceutical formulations | Feb 27, 2020 | Issued |
Array
(
[id] => 16266486
[patent_doc_number] => 20200267973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ALKALINE DISINFECTING COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/796990
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796990 | ALKALINE DISINFECTING COMPOSITIONS | Feb 20, 2020 | Pending |
Array
(
[id] => 20385425
[patent_doc_number] => 12485134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations
[patent_app_type] => utility
[patent_app_number] => 16/798207
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 30
[patent_no_of_words] => 27281
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798207 | Use of nicotinamide riboside, nicotinic acid riboside, reduced nicotinyl riboside compounds, and nicotinyl riboside compound derivatives in formulations | Feb 20, 2020 | Issued |
Array
(
[id] => 16435578
[patent_doc_number] => 20200352903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => Choline Esters
[patent_app_type] => utility
[patent_app_number] => 16/791265
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791265 | Choline Esters | Feb 13, 2020 | Abandoned |
Array
(
[id] => 18399303
[patent_doc_number] => 11661429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Topical phosphoinositide 3-kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/783050
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 29326
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783050
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/783050 | Topical phosphoinositide 3-kinase inhibitors | Feb 4, 2020 | Issued |
Array
(
[id] => 15926141
[patent_doc_number] => 20200154704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => FOOD CONTACT SURFACE SANITIZING LIQUID
[patent_app_type] => utility
[patent_app_number] => 16/773687
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773687
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773687 | Food contact surface sanitizing liquid | Jan 26, 2020 | Issued |
Array
(
[id] => 18012053
[patent_doc_number] => 11504327
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-22
[patent_title] => Method of preparing nanoparticles by hot-melt extrusion
[patent_app_type] => utility
[patent_app_number] => 16/748399
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33368
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16748399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/748399 | Method of preparing nanoparticles by hot-melt extrusion | Jan 20, 2020 | Issued |
Array
(
[id] => 15894869
[patent_doc_number] => 20200146953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => LIQUID CONCENTRATE FOR PRESERVING COSMETICS
[patent_app_type] => utility
[patent_app_number] => 16/741383
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16741383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/741383 | LIQUID CONCENTRATE FOR PRESERVING COSMETICS | Jan 12, 2020 | Abandoned |
Array
(
[id] => 15895405
[patent_doc_number] => 20200147221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/739506
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739506 | High capacity diketopiperazine microparticles and methods | Jan 9, 2020 | Issued |
Array
(
[id] => 17952420
[patent_doc_number] => 11478493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers
[patent_app_type] => utility
[patent_app_number] => 16/735977
[patent_app_country] => US
[patent_app_date] => 2020-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 9237
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16735977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/735977 | Fabrication and application of a hetero-targeted nano-cocktail with traceless linkers | Jan 6, 2020 | Issued |
Array
(
[id] => 16236644
[patent_doc_number] => 20200253878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/724527
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32010
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724527
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724527 | COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF | Dec 22, 2019 | Abandoned |
Array
(
[id] => 17741375
[patent_doc_number] => 11389418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Protection of polyunsaturated fatty acids from ruminal degradation
[patent_app_type] => utility
[patent_app_number] => 16/722358
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6575
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722358
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/722358 | Protection of polyunsaturated fatty acids from ruminal degradation | Dec 19, 2019 | Issued |
Array
(
[id] => 17525707
[patent_doc_number] => 11298373
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-12
[patent_title] => Bowel cleansing chemical composition and associated use therefore
[patent_app_type] => utility
[patent_app_number] => 16/721688
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4990
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721688
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/721688 | Bowel cleansing chemical composition and associated use therefore | Dec 18, 2019 | Issued |
Array
(
[id] => 15963641
[patent_doc_number] => 20200165572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => ENGINEERED SUBSTRATES FOR HIGH-THROUGHPUT GENERATION OF 3D MODELS OF TUMOR DORMANCY, RELAPSE AND MICROMETASTASES FOR PHENOTYPE SPECIFIC DRUG DISCOVERY AND DEVELOPMENT
[patent_app_type] => utility
[patent_app_number] => 16/708027
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/708027 | ENGINEERED SUBSTRATES FOR HIGH-THROUGHPUT GENERATION OF 3D MODELS OF TUMOR DORMANCY, RELAPSE AND MICROMETASTASES FOR PHENOTYPE SPECIFIC DRUG DISCOVERY AND DEVELOPMENT | Dec 8, 2019 | Abandoned |
Array
(
[id] => 18043624
[patent_doc_number] => 11517556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Composition for BK
[patent_app_type] => utility
[patent_app_number] => 16/675656
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 10663
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 314
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16675656
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/675656 | Composition for BK | Nov 5, 2019 | Issued |
Array
(
[id] => 18931119
[patent_doc_number] => 11883514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Stable low pH personal care compositions and methods for the same
[patent_app_type] => utility
[patent_app_number] => 16/671996
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10458
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16671996
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/671996 | Stable low pH personal care compositions and methods for the same | Oct 31, 2019 | Issued |
Array
(
[id] => 15523435
[patent_doc_number] => 20200054023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => NOVEL PAENIBACILLUS STRAIN, ANTIFUNGAL COMPOUNDS, AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/669783
[patent_app_country] => US
[patent_app_date] => 2019-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16669783
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/669783 | Paenibacillus strain, antifungal compounds, and methods for their use | Oct 30, 2019 | Issued |
Array
(
[id] => 15557015
[patent_doc_number] => 20200062919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Dendritic Macroporous Hydrogels Prepared By Crystal Templating
[patent_app_type] => utility
[patent_app_number] => 16/597106
[patent_app_country] => US
[patent_app_date] => 2019-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16597106
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/597106 | Dendritic macroporous hydrogels prepared by crystal templating | Oct 8, 2019 | Issued |